Nobel Prize Recognizes Groundbreaking Immune System Research
The Nobel Prize in medical science has been granted for revolutionary findings that clarify how the body's defense network attacks dangerous infections while sparing the healthy tissues.
Three renowned researchers—Japan's Shimon Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.
The research uncovered specialized "security guards" within the immune system that eliminate malfunctioning defense cells capable of attacking the organism.
These findings are now enabling innovative therapies for autoimmune diseases and cancer.
These winners will divide a prize fund worth 11 million SEK.
Decisive Discoveries
"Their research has been essential for comprehending how the body's defenses functions and the reason we don't all develop serious autoimmune diseases," stated the head of the Nobel Committee.
This team's studies address a fundamental mystery: In what way does the defense system protect us from numerous invaders while leaving our own tissues intact?
Our immune system uses white blood cells that search for indicators of disease, even viruses and bacteria it has not met before.
Such defenders employ detectors—called recognition units—that are produced by chance in countless combinations.
This gives the defense network the ability to combat a wide array of threats, but the randomness of the mechanism unavoidably creates white blood cells that can target the body.
Security Guards of the Immune System
Researchers previously knew that a portion of these problematic defense cells were eliminated in the immune organ—where immune cells develop.
The latest award honors the identification of T-reg cells—described as the body's "peacekeepers"—which patrol the system to neutralize any defenders that attack the healthy cells.
It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and RA.
The prize committee stated, "The discoveries have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for example for tumors and autoimmune diseases."
In malignancies, regulatory T-cells block the system from fighting the tumor, so research are focused on lowering their numbers.
In autoimmune diseases, trials are testing boosting T-reg cells so the body is no longer under attack. A comparable method could also be useful in minimizing the risks of transplanted organ failure.
Pioneering Studies
Professor Sakaguchi, of a Japanese institution, conducted tests on mice that had their thymus removed, causing self-attack conditions.
The researcher showed that injecting defense cells from other mice could prevent the illness—suggesting there was a system for preventing defenders from attacking the host.
Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in mice and people that led to the identification of a genetic factor critical for how T-regs function.
"Their pioneering work has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally targeting the body's own tissues," said a leading biological science specialist.
"The work is a remarkable illustration of how basic physiological study can have far-reaching consequences for public health."
